(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADOCIA, AB SCIENCE, and IEX GROUP NV.

Financial Asset	Price	Change	Updated (EST)
ADOCIA (ADOC.PA)	8.50	16.44%	2023-10-02 12:45:54
AB SCIENCE (AB.PA)	2.67	12.42%	2023-10-02 12:45:26
IEX GROUP NV (IEX.AS)	1.95	11.43%	2023-10-02 12:02:49
KMC PROPERTIES (KMCP.OL)	6.06	10.99%	2023-10-02 12:40:59
BERGENBIO (BGBIO.OL)	0.12	10.95%	2023-10-02 12:25:55
ALUMEXX N.V. (ALX.AS)	0.75	8.76%	2023-10-02 12:00:27
SPORTING (SCP.LS)	0.93	5.11%	2023-10-02 12:24:39
WAREHOUSES ESTATES (WEB.BR)	34.00	4.94%	2023-10-02 12:22:25
DNO (DNO.OL)	11.08	4.82%	2023-10-02 12:26:34
IEP INVEST (IEP.BR)	5.70	4.59%	2023-10-02 12:20:19

The three biggest losers today are TECHSTEP, ZAPTEC, and BIOTALYS.

Financial Asset	Price	Change	Updated (EST)
TECHSTEP (TECH.OL)	9.02	-9.49%	2023-10-02 12:44:34
ZAPTEC (ZAP.OL)	24.28	-8.65%	2023-10-02 12:45:24
BIOTALYS (BTLS.BR)	4.30	-8.51%	2023-10-02 12:06:08
AUREA (AURE.PA)	4.90	-8.24%	2023-10-02 12:47:12
MITHRA (MITRA.BR)	1.30	-7.41%	2023-10-02 12:20:51
OCEANTEAM (OTS.OL)	1.48	-7.21%	2023-10-02 12:42:02
ELMERA GROUP (ELMRA.OL)	24.34	-7.17%	2023-10-02 12:26:50
FLOW TRADERS (FLOW.AS)	16.45	-6.59%	2023-10-02 12:02:19
PCI BIOTECH HOLD (PCIB.OL)	1.43	-6.28%	2023-10-02 12:42:27
GLINTT (GLINT.LS)	0.36	-5.82%	2023-10-02 12:23:56

Winners today

1. ADOCIA (ADOC.PA)

16.44% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 16.44% to €8.50 on Monday while CAC 40 dropped 0.94% to €7,068.16.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-2.62.

More news about ADOCIA.

2. AB SCIENCE (AB.PA)

12.42% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE jumping 12.42% to €2.67 on Monday while CAC 40 fell 0.94% to €7,068.16.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.3.

Revenue Growth

Year-on-year quarterly revenue growth declined by 58.3%, now sitting on 958k for the twelve trailing months.

More news about AB SCIENCE.

3. IEX GROUP NV (IEX.AS)

11.43% Price Change

IEX Group N.V., through its subsidiaries, operates financial websites in the Netherlands and Belgium. It operates Beurs.nl, Belegger.nl, Beleggen.nl, DeBeurs.nl, Beursonline.nl, Participaties.nl, Beursgorilla.nl, Tostrams.nl and Guruwatch websites. The company also provides investment information services. In addition, the company offers IEX Expert and IEX Profs magazine for various investors; and organizes various events for private individuals and professionals. IEX Group N.V. was founded in 1999 and is based in Amsterdam, the Netherlands.

AEX-Index ended the session with IEX GROUP NV rising 11.43% to €1.95 on Monday while AEX-Index slid 0.63% to €724.18.

Earnings Per Share

As for profitability, IEX GROUP NV has a trailing twelve months EPS of €0.25.

PE Ratio

IEX GROUP NV has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing €7.8 for every euro of annual earnings.

Volume

Today’s last reported volume for IEX GROUP NV is 333 which is 40.32% below its average volume of 558.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 5.13M for the twelve trailing months.

Yearly Top and Bottom Value

IEX GROUP NV’s stock is valued at €1.95 at 22:40 EST, below its 52-week high of €2.00 and way above its 52-week low of €1.50.

Moving Average

IEX GROUP NV’s value is above its 50-day moving average of €1.88 and way above its 200-day moving average of €1.75.

More news about IEX GROUP NV.

4. KMC PROPERTIES (KMCP.OL)

10.99% Price Change

KMC Properties ASA, a real estate company, owns and operates industrial and logistics properties. It owns a portfolio of 44 properties in the Nordics and the Netherlands, as well as an office building in Moscow, Russia. The company was incorporated in 2020 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with KMC PROPERTIES rising 10.99% to €6.06 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.76% to €1,281.21, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, KMC PROPERTIES has a trailing twelve months EPS of kr0.21.

PE Ratio

KMC PROPERTIES has a trailing twelve months price to earnings ratio of 28.86. Meaning, the purchaser of the share is investing kr28.86 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.01%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

KMC PROPERTIES’s EBITDA is 56.54.

Moving Average

KMC PROPERTIES’s worth is way higher than its 50-day moving average of kr5.36 and above its 200-day moving average of kr6.01.

Sales Growth

KMC PROPERTIES’s sales growth is 63.3% for the current quarter and 30.4% for the next.

More news about KMC PROPERTIES.

5. BERGENBIO (BGBIO.OL)

10.95% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 10.95% to €0.12 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.76% to €1,281.21, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.69.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BERGENBIO’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.12 at 22:40 EST, way under its 52-week high of kr13.03 and way higher than its 52-week low of kr0.08.

More news about BERGENBIO.

6. ALUMEXX N.V. (ALX.AS)

8.76% Price Change

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

AEX-Index ended the session with ALUMEXX N.V. jumping 8.76% to €0.75 on Monday while AEX-Index slid 0.63% to €724.18.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.01.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 74.5. Meaning, the purchaser of the share is investing €74.5 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.6%, now sitting on 8.08M for the twelve trailing months.

Yearly Top and Bottom Value

ALUMEXX N.V.’s stock is valued at €0.75 at 22:40 EST, higher than its 52-week high of €0.74.

Volume

Today’s last reported volume for ALUMEXX N.V. is 36344 which is 883.86% above its average volume of 3694.

Moving Average

ALUMEXX N.V.’s worth is above its 50-day moving average of €0.69 and way higher than its 200-day moving average of €0.67.

More news about ALUMEXX N.V..

7. SPORTING (SCP.LS)

5.11% Price Change

Sporting Clube de Portugal – Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal – Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.

PSI ended the session with SPORTING rising 5.11% to €0.93 on Monday while PSI dropped 0.42% to €6,064.71.

Earnings Per Share

As for profitability, SPORTING has a trailing twelve months EPS of €0.13.

PE Ratio

SPORTING has a trailing twelve months price to earnings ratio of 7.12. Meaning, the purchaser of the share is investing €7.12 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SPORTING’s stock is considered to be oversold (<=20).

More news about SPORTING.

8. WAREHOUSES ESTATES (WEB.BR)

4.94% Price Change

Warehouses Estates Belgium SCA is a real estate investment trust. Warehouses Estates Belgium SCA is based in Belgium.

BEL 20 ended the session with WAREHOUSES ESTATES jumping 4.94% to €34.00 on Monday while BEL 20 fell 1.22% to €3,509.67.

Earnings Per Share

As for profitability, WAREHOUSES ESTATES has a trailing twelve months EPS of €3.84.

PE Ratio

WAREHOUSES ESTATES has a trailing twelve months price to earnings ratio of 8.85. Meaning, the purchaser of the share is investing €8.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.31%.

More news about WAREHOUSES ESTATES.

9. DNO (DNO.OL)

4.82% Price Change

DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. Its flagship project is the Tawke field that is located in the Kurdistan region of Iraq. The company was founded in 1971 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with DNO jumping 4.82% to €11.08 on Monday while Oslo Børs Benchmark Index_GI dropped 0.76% to €1,281.21.

Earnings Per Share

As for profitability, DNO has a trailing twelve months EPS of kr2.58.

PE Ratio

DNO has a trailing twelve months price to earnings ratio of 4.29. Meaning, the purchaser of the share is investing kr4.29 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.33%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 83.8%, now sitting on 1B for the twelve trailing months.

Yearly Top and Bottom Value

DNO’s stock is valued at kr11.08 at 22:40 EST, way under its 52-week high of kr15.20 and way higher than its 52-week low of kr9.30.

Volatility

DNO’s last week, last month’s, and last quarter’s current intraday variation average was 0.88%, 0.20%, and 1.75%.

DNO’s highest amplitude of average volatility was 1.58% (last week), 1.38% (last month), and 1.75% (last quarter).

More news about DNO.

10. IEP INVEST (IEP.BR)

4.59% Price Change

Iep Invest, NV is an investment firm specializing in investments in and loans to real estate companies. The firm previously operated as manufacturing group. It was formerly known as Punch International nv and changed its name to Iep Invest, NV in May 2014. Iep Invest, NV was founded in 1982 and is based in Antwerp, Belgium.

BEL 20 ended the session with IEP INVEST rising 4.59% to €5.70 on Monday while BEL 20 fell 1.22% to €3,509.67.

Earnings Per Share

As for profitability, IEP INVEST has a trailing twelve months EPS of €-0.22.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.52%.

Volume

Today’s last reported volume for IEP INVEST is 4563 which is 689.44% above its average volume of 578.

Volatility

IEP INVEST’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.67%, a positive 0.29%, and a positive 2.37%.

IEP INVEST’s highest amplitude of average volatility was 3.67% (last week), 2.83% (last month), and 2.37% (last quarter).

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Oct 3, 2022, the estimated forward annual dividend rate is 5 and the estimated forward annual dividend yield is 90.91%.

More news about IEP INVEST.

Losers Today

1. TECHSTEP (TECH.OL)

-9.49% Price Change

Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TECHSTEP dropping 9.49% to €9.02 on Monday, after four sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 0.76% to €1,281.21, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, TECHSTEP has a trailing twelve months EPS of kr-2.51.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.38%.

Moving Average

TECHSTEP’s worth is way below its 50-day moving average of kr11.08 and way under its 200-day moving average of kr12.91.

Volume

Today’s last reported volume for TECHSTEP is 121792 which is 29.18% below its average volume of 171976.

More news about TECHSTEP.

2. ZAPTEC (ZAP.OL)

-8.65% Price Change

Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go, a charging unit for use in homes, private garages, or parking spaces; Zaptec Pro, a charging station for parking spaces in housing cooperatives and co-ownership properties, companies, and newbuilds; charging stations for outdoor installations; Zaptec Park, an automatic payment solution; Zaptec Portal for monitoring, balancing, and optimizing the load between the various charging stations; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company was founded in 2012 and is based in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with ZAPTEC dropping 8.65% to €24.28 on Monday while Oslo Børs Benchmark Index_GI slid 0.76% to €1,281.21.

Earnings Per Share

As for profitability, ZAPTEC has a trailing twelve months EPS of kr-0.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.12%.

More news about ZAPTEC.

3. BIOTALYS (BTLS.BR)

-8.51% Price Change

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

BEL 20 ended the session with BIOTALYS sliding 8.51% to €4.30 on Monday, after two successive sessions in a row of losses. BEL 20 dropped 1.22% to €3,509.67, following the last session’s upward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, BIOTALYS has a trailing twelve months EPS of €-0.76.

Volatility

BIOTALYS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.21%, a negative 1.00%, and a positive 1.47%.

BIOTALYS’s highest amplitude of average volatility was 0.50% (last week), 1.79% (last month), and 1.47% (last quarter).

More news about BIOTALYS.

4. AUREA (AURE.PA)

-8.24% Price Change

Aurea SA engages in the recycling of black motor oil in France. The company is also involved in the manufacturing of remold tires from used tires and recycling rigid PVC. It recycles plastics and packaging products; refines and recycles aluminum; recycles copper and produces copper alloys; and treats and recycles zinc, lead, and cadmium. In addition, the comany engages in the treatment and decontamination of mercury waste. The company was formerly known as AUER and changed its name to Aurea SA in 1988. Aurea SA is based in Paris, France.

CAC 40 ended the session with AUREA sliding 8.24% to €4.90 on Monday, after two successive sessions in a row of gains. CAC 40 fell 0.94% to €7,068.16, after two sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, AUREA has a trailing twelve months EPS of €0.34.

PE Ratio

AUREA has a trailing twelve months price to earnings ratio of 14.41. Meaning, the purchaser of the share is investing €14.41 for every euro of annual earnings.

Volatility

AUREA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.98%, a negative 0.75%, and a positive 2.24%.

AUREA’s highest amplitude of average volatility was 7.79% (last week), 3.56% (last month), and 2.24% (last quarter).

Volume

Today’s last reported volume for AUREA is 2337 which is 24.64% above its average volume of 1875.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUREA’s stock is considered to be oversold (<=20).

More news about AUREA.

5. MITHRA (MITRA.BR)

-7.41% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA falling 7.41% to €1.30 on Monday while BEL 20 slid 1.22% to €3,509.67.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -575.59%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MITHRA’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 38.1%, now sitting on 62.67M for the twelve trailing months.

Volume

Today’s last reported volume for MITHRA is 416301 which is 30.35% above its average volume of 319363.

Yearly Top and Bottom Value

MITHRA’s stock is valued at €1.30 at 22:40 EST, way under its 52-week high of €6.87 and higher than its 52-week low of €1.25.

More news about MITHRA.

6. OCEANTEAM (OTS.OL)

-7.21% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM falling 7.21% to €1.48 on Monday while Oslo Børs Benchmark Index_GI fell 0.76% to €1,281.21.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OCEANTEAM’s stock is considered to be overbought (>=80).

Moving Average

OCEANTEAM’s worth is below its 50-day moving average of kr1.64 and below its 200-day moving average of kr1.59.

Volatility

OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.13%, a negative 0.19%, and a positive 3.44%.

OCEANTEAM’s highest amplitude of average volatility was 1.44% (last week), 2.82% (last month), and 3.44% (last quarter).

More news about OCEANTEAM.

7. ELMERA GROUP (ELMRA.OL)

-7.17% Price Change

Elmera Group ASA, together with its subsidiaries, engages in the purchase, sale, and portfolio management of electrical power to households, private and public companies, and municipalities in Norway. It operates through Consumer, Business, and Nordic segments. The Consumer segment sells electrical power and related services to private consumers. The Business segment sells electrical power and related services to business consumers. The Nordic segment sells electrical power and related services to consumers in Finland and Sweden. The company also manages, researches, and develops products and services related to electrical power; and offers payment solutions. In addition, it provides mobile phone services to private customers. The company was formerly known as Fjordkraft Holding ASA and changed its name to Elmera Group ASA in April 2022. Elmera Group ASA was founded in 2001 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELMERA GROUP falling 7.17% to €24.34 on Monday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.76% to €1,281.21, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ELMERA GROUP has a trailing twelve months EPS of kr0.11.

PE Ratio

ELMERA GROUP has a trailing twelve months price to earnings ratio of 221.27. Meaning, the purchaser of the share is investing kr221.27 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.

Volatility

ELMERA GROUP’s last week, last month’s, and last quarter’s current intraday variation average was 2.25%, 0.87%, and 1.71%.

ELMERA GROUP’s highest amplitude of average volatility was 2.25% (last week), 1.85% (last month), and 1.71% (last quarter).

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 27, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 6.79%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ELMERA GROUP’s EBITDA is 0.13.

Moving Average

ELMERA GROUP’s worth is way higher than its 50-day moving average of kr21.32 and way above its 200-day moving average of kr18.87.

More news about ELMERA GROUP.

8. FLOW TRADERS (FLOW.AS)

-6.59% Price Change

Flow Traders Ltd. operates as a financial technology-enabled multi-asset class liquidity provider in Europe, the Americas, and Asia. The company provides liquidity support that allows investors to continue to buy or sell exchange traded products or other financial instruments. It offers liquidity through on screen, which is conducted on stock exchanges; and off exchange through request for quote platforms. The company was founded in 2004 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with FLOW TRADERS dropping 6.59% to €16.45 on Monday while AEX-Index dropped 0.63% to €724.18.

Earnings Per Share

As for profitability, FLOW TRADERS has a trailing twelve months EPS of €1.87.

PE Ratio

FLOW TRADERS has a trailing twelve months price to earnings ratio of 8.8. Meaning, the purchaser of the share is investing €8.8 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.86%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 92% and a negative 56.9%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FLOW TRADERS’s stock is considered to be oversold (<=20).

Sales Growth

FLOW TRADERS’s sales growth is negative 19.5% for the present quarter and negative 34.7% for the next.

More news about FLOW TRADERS.

9. PCI BIOTECH HOLD (PCIB.OL)

-6.28% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD dropping 6.28% to €1.43 on Monday while Oslo Børs Benchmark Index_GI slid 0.76% to €1,281.21.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PCI BIOTECH HOLD’s EBITDA is -4.54.

More news about PCI BIOTECH HOLD.

10. GLINTT (GLINT.LS)

-5.82% Price Change

Glintt – Global Intelligent Technologies, S.A. provides IT and consulting services in Portugal and internationally. The company offers business consulting services, such as pharmacy management, continuous, diagnostic, and project consulting; and IT consulting services, including applications and technology consulting, business process management, and data analytics. It also provides IT infrastructure services comprising cloud and datacenter, service and application management, networking and security, and information security; physical design and automation, and software solutions; and integrated application and equipment support services. The company primarily serves the healthcare, pharma, financial services, and telecommunications markets, as well as the public sector. Glintt – Global Intelligent Technologies, S.A. was incorporated in 1995 and is based in Sintra, Portugal.

PSI ended the session with GLINTT sliding 5.82% to €0.36 on Monday while PSI slid 0.42% to €6,064.71.

Earnings Per Share

As for profitability, GLINTT has a trailing twelve months EPS of €0.04.

PE Ratio

GLINTT has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing €8.9 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.84%.

More news about GLINTT.

Stay up to date with our winners and losers daily report